Recombinant Human OPRD1 Protein，His

OPRD1, also known as the delta-opioid receptor (DOR), is a vital member of the opioid receptor family, which plays a crucial role in modulating pain, mood, and stress responses in the central nervous system. The study of OPRD1 recombination proteins has garnered significant interest due to their potential therapeutic implications in treating various conditions, including chronic pain, depression, and addiction. The delta-opioid receptor exhibits a unique pharmacological profile distinct from the mu-opioid receptor, leading to a lower risk of addiction while still providing analgesic effects. Research has focused on elucidating the molecular mechanisms underlying OPRD1 signaling, receptor dimerization, and interactions with other cellular proteins. Recombinant OPRD1 proteins are instrumental in assessing drug efficacy and specificity, as well as in understanding receptor dynamics in neuronal models. Furthermore, advancements in biotechnology enable the characterization of OPRD1 variants, offering insights into individual differences in drug response and susceptibility to opioid-related disorders. As the opioid crisis emphasizes the need for safer pain management alternatives, OPRD1 represents a promising target for the development of novel therapeutics. Ongoing studies aim to optimize OPRD1-based drugs that exploit its analgesic properties while minimizing side effects, ultimately contributing to more effective and responsible pain management strategies.